| Literature DB >> 24021253 |
Dana Meaney-Delman1, Cecelia A Bellcross.
Abstract
An understanding of the diagnosis and clinical management of hereditary breast and ovarian cancer syndrome (HBOC) is essential for obstetricians/gynecologists. This article provides practical information regarding collecting a family history, cancer risk assessment and genetic testing, BRCA-associated cancer prognosis and treatment, screening recommendations, and prevention strategies. Through appropriate cancer risk assessment, women with BRCA1/2 mutations can be identified, and screening and prevention strategies can be used before a diagnosis of cancer occurs. Women's health providers with a strong working knowledge of HBOC are able to improve the quality of care for women and families impacted by BRCA1/2 mutations. Published by Elsevier Inc.Entities:
Keywords: BRCA1; BRCA2; Clinical management; Genetic testing; Hereditary breast cancer; Hereditary ovarian cancer
Mesh:
Substances:
Year: 2013 PMID: 24021253 DOI: 10.1016/j.ogc.2013.05.009
Source DB: PubMed Journal: Obstet Gynecol Clin North Am ISSN: 0889-8545 Impact factor: 2.844